56 related articles for article (PubMed ID: 8058334)
1. Differential protein binding to the c-myc promoter during differentiation of hematopoietic cell lines.
Arcinas M; Boxer LM
Oncogene; 1994 Sep; 9(9):2699-706. PubMed ID: 8058334
[TBL] [Abstract][Full Text] [Related]
2. Changes in in vivo protein-DNA interactions occur at the c-myc P2 promoter during differentiation.
Bryans M; Lang JC; Wilkie NM
Biochem Biophys Res Commun; 1993 Dec; 197(3):1363-9. PubMed ID: 8280153
[TBL] [Abstract][Full Text] [Related]
3. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.
Bentley DL; Groudine M
Nature; 1986 Jun 12-18; 321(6071):702-6. PubMed ID: 3520340
[TBL] [Abstract][Full Text] [Related]
4. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
Ishida S; Shudo K; Takada S; Koike K
Cell Growth Differ; 1994 Mar; 5(3):287-94. PubMed ID: 8018561
[TBL] [Abstract][Full Text] [Related]
5. A protein binding site from the murine c-myc promoter contributes to transcriptional block.
Dufort D; Drolet M; Nepveu A
Oncogene; 1993 Jan; 8(1):165-71. PubMed ID: 8423994
[TBL] [Abstract][Full Text] [Related]
6. DNA repair in the MYC and FMS proto-oncogenes in ultraviolet light-irradiated human HL60 promyelocytic cells during differentiation.
Islas AL; Hanawalt PC
Cancer Res; 1995 Jan; 55(2):336-41. PubMed ID: 7529133
[TBL] [Abstract][Full Text] [Related]
7. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
[TBL] [Abstract][Full Text] [Related]
8. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
Kujoth GC; Fahl WE
Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
[TBL] [Abstract][Full Text] [Related]
9. c-Myc promoter activation in medulloblastoma.
Siu IM; Lal A; Blankenship JR; Aldosari N; Riggins GJ
Cancer Res; 2003 Aug; 63(16):4773-6. PubMed ID: 12941792
[TBL] [Abstract][Full Text] [Related]
10. c-myc promoter binding protein regulates the cellular response to an altered glucose concentration.
Sedoris KC; Thomas SD; Miller DM
Biochemistry; 2007 Jul; 46(29):8659-68. PubMed ID: 17595061
[TBL] [Abstract][Full Text] [Related]
11. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
12. Sequence-specific binding of a c-myc nuclear-matrix-associated region shows increased nuclear matrix retention after leukemic cell (HL-60) differentiation.
Chou RH; Churchill JR; Mapstone DE; Flubacher MM
Am J Anat; 1991 Jul; 191(3):312-20. PubMed ID: 1927975
[TBL] [Abstract][Full Text] [Related]
13. In vivo footprints between the murine c-myc P1 and P2 promoters.
Plet A; Tourkine N; Mechti N; Jeanteur P; Blanchard JM
Oncogene; 1992 Sep; 7(9):1847-51. PubMed ID: 1501892
[TBL] [Abstract][Full Text] [Related]
14. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
[TBL] [Abstract][Full Text] [Related]
15. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
16. A binding protein to the DNase I hypersensitive site II in HLA-DR alpha gene was identified as NF90.
Sakamoto S; Morisawa K; Ota K; Nie J; Taniguchi T
Biochemistry; 1999 Mar; 38(11):3355-61. PubMed ID: 10079079
[TBL] [Abstract][Full Text] [Related]
17. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation.
Madireddi MT; Dent P; Fisher PB
J Cell Physiol; 2000 Oct; 185(1):36-46. PubMed ID: 10942517
[TBL] [Abstract][Full Text] [Related]
18. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
19. Differentiation-specific transcriptional regulation of the ESE-2 gene by a novel keratinocyte-restricted factor.
Tummala R; Sinha S
J Cell Biochem; 2006 Mar; 97(4):766-81. PubMed ID: 16229011
[TBL] [Abstract][Full Text] [Related]
20. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
